OrthoPediatrics Corp. (NASDAQ:KIDS) EVP Sells $79,695.00 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDSGet Rating) EVP Gregory A. Odle sold 1,771 shares of the stock in a transaction on Friday, January 13th. The stock was sold at an average price of $45.00, for a total value of $79,695.00. Following the transaction, the executive vice president now directly owns 73,125 shares in the company, valued at approximately $3,290,625. The transaction was disclosed in a filing with the SEC, which is available at this link.

OrthoPediatrics Stock Performance

OrthoPediatrics stock opened at $44.15 on Wednesday. The stock has a 50-day moving average of $41.38 and a two-hundred day moving average of $45.18. OrthoPediatrics Corp. has a one year low of $35.67 and a one year high of $60.75. The stock has a market cap of $1.01 billion, a PE ratio of 116.18 and a beta of 0.80.

OrthoPediatrics (NASDAQ:KIDSGet Rating) last released its quarterly earnings results on Monday, October 31st. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.14. OrthoPediatrics had a negative return on equity of 5.60% and a net margin of 7.90%. The company had revenue of $34.95 million during the quarter, compared to analysts’ expectations of $36.44 million. As a group, sell-side analysts predict that OrthoPediatrics Corp. will post -0.69 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Point72 Hong Kong Ltd purchased a new position in shares of OrthoPediatrics in the first quarter worth about $26,000. MCF Advisors LLC purchased a new position in shares of OrthoPediatrics in the third quarter worth about $33,000. Almanack Investment Partners LLC. purchased a new position in shares of OrthoPediatrics in the third quarter worth about $34,000. Lazard Asset Management LLC purchased a new position in shares of OrthoPediatrics in the first quarter worth about $65,000. Finally, Harbor Investment Advisory LLC raised its stake in shares of OrthoPediatrics by 24.3% in the second quarter. Harbor Investment Advisory LLC now owns 1,578 shares of the company’s stock worth $68,000 after purchasing an additional 308 shares during the last quarter. 97.02% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on KIDS. Piper Sandler dropped their price target on OrthoPediatrics from $58.00 to $52.00 in a research report on Tuesday, November 1st. Stifel Nicolaus dropped their price objective on OrthoPediatrics from $52.00 to $50.00 and set a “buy” rating on the stock in a research report on Tuesday, January 10th. TheStreet raised OrthoPediatrics from a “d+” rating to a “c” rating in a research report on Tuesday, November 1st. JMP Securities dropped their price objective on OrthoPediatrics from $70.00 to $60.00 and set a “market outperform” rating on the stock in a research report on Wednesday, November 2nd. Finally, Needham & Company LLC dropped their price objective on OrthoPediatrics from $59.00 to $50.00 and set a “buy” rating on the stock in a research report on Tuesday, November 1st. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $54.33.

OrthoPediatrics Company Profile

(Get Rating)

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Featured Articles

Insider Buying and Selling by Quarter for OrthoPediatrics (NASDAQ:KIDS)

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.